Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mustafa Korkut Uygun
Massachusetts General Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Organ Solutions, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Uygun is a co-founder of Organ Solutions, LLC. The company is developing perfusion systems and services for organ preservation with the goal of improving organ viability and maximizing the time to transplant. This research grant will develop theranostic cell biosensors to monitor and locally treat transplanted organs. The results of this research may be of interest to Organ Solutions, LLC. The Partners Healthcare Committee on Outside Activities review panel evaluated the financial interest in connection with this research and determined that
the financial interest could directly and significantly affect the design, conduct, or reporting of the research.
Theranostic approach to transplant rejection using engineered cell biosensors
Narrative Rejection of a liver transplant can be a devastating outcome for patients and a huge economic toll on society. This application uses a genetically engineered cell that is engrafted into the liver prior to transplant to sense inflammation and simultaneously release a blood-based biomarker and local therapeutic. The significance of this research program is to bring to bear a new theranostic biosensor strategy for the real-time, in situ monitoring and management of an organ transplant.
Filed on June 12, 2018.
Tell us what you know about Mustafa Korkut Uygun's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Mustafa Korkut Uygun filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Mustafa Korkut Uygun | Massachusetts General Hospital | Conflict of Interest | Organ Solutions, LLC | Value cannot be readily determined |
| Korkut Uygun | Massachusetts General Hospital | Conflict of Interest | Organ Solutions, LLC | Value cannot be readily determined |
| Korkut Mustafa Uygun | Massachusetts General Hospital | Conflict of Interest | Organ Solutions, LLC | Value cannot be readily determined |
| Mustafa Korkut Uygun | Massachusetts General Hospital | Conflict of Interest | Organ Solutions, LLC | Value cannot be readily determined |
| Korkut Uygun | Massachusetts General Hospital | Conflict of Interest | Organ Solutions, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.